Skip to content
10-Q

Quarterly Report

Apollo Endosurgery, Inc.

0001251769-22-000034

← back to feed
Filed
May 3, 2022 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Apr 29, 2022 40.25M sh
Shares Diluted Q1 2022 · Mar 31, 2022 39.65M sh
Shares Diluted Q1 2022 · Mar 31, 2021 26.31M sh
Capex Q1 2022 · Mar 31, 2022 $467K
Capex Q1 2022 · Mar 31, 2021 $221K
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$8.69M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$4.31M
Long Term Debt Q1 2022 · Mar 31, 2022 $33.59M
Long Term Debt Q1 2022 · Dec 31, 2021 $33.47M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $81.73M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $90.69M
Stockholders Equity Q1 2022 · Mar 31, 2022 $55.03M
Stockholders Equity Q1 2022 · Dec 31, 2021 $61.24M
Stockholders Equity Q1 2022 · Mar 31, 2021 $2.69M
Stockholders Equity Q1 2022 · Dec 31, 2020 $6.75M
Current Liabilities Q1 2022 · Mar 31, 2022 $13.95M
Current Liabilities Q1 2022 · Dec 31, 2021 $14.49M
Total Liabilities Q1 2022 · Mar 31, 2022 $69.98M
Total Liabilities Q1 2022 · Dec 31, 2021 $70.29M
Current Assets Q1 2022 · Mar 31, 2022 $108.5M
Current Assets Q1 2022 · Dec 31, 2021 $114.7M
Total Assets Q1 2022 · Mar 31, 2022 $125.02M
Total Assets Q1 2022 · Dec 31, 2021 $131.53M
Eps Diluted Q1 2022 · Mar 31, 2022 −$0.21
Eps Diluted Q1 2022 · Mar 31, 2021 −$0.17
Eps Basic Q1 2022 · Mar 31, 2022 −$0.21
Eps Basic Q1 2022 · Mar 31, 2021 −$0.17
Sga Expense Q1 2022 · Mar 31, 2022 $5.23M
Sga Expense Q1 2022 · Mar 31, 2021 $4.07M
Rd Expense Q1 2022 · Mar 31, 2022 $2.71M
Rd Expense Q1 2022 · Mar 31, 2021 $1.93M
Net Income Q1 2022 · Mar 31, 2022 −$8.41M
Net Income Q1 2022 · Mar 31, 2021 −$4.6M
Operating Income Q1 2022 · Mar 31, 2022 −$7.25M
Operating Income Q1 2022 · Mar 31, 2021 −$3.75M
Gross Profit Q1 2022 · Mar 31, 2022 $9.37M
Gross Profit Q1 2022 · Mar 31, 2021 $7.51M
Revenue Q1 2022 · Mar 31, 2022 $16.66M
Revenue Q1 2022 · Mar 31, 2021 $13.86M